BVS logo

BVS

Bioventus Inc.NASDAQHealthcare
$8.97-1.97%ClosedMarket Cap: $604.3M

As of 2026-04-06

Valuation

View Details

P/E (TTM)

26.58

PEG

0.16

P/B

3.25

P/S

1.06

EV/EBITDA

8.19

DCF Value

$-2.29

FCF Yield

11.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

67.3%

Operating Margin

10.0%

Net Margin

4.0%

ROE

13.8%

ROA

7.4%

ROIC

10.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$157.9M$14.8M$0.21
FY 2025$568.1M$22.7M$0.33
Q3 2025$138.7M$3.2M$0.05
Q2 2025$147.7M$7.5M$0.11

Analyst Ratings

View All
Craig-HallumBuy
2026-03-06
Barrington ResearchOutperform
2026-03-06

Trading Activity

Insider Trades

View All
Singleton Mark Leonardofficer: SVP & CFO
SellTue Mar 24
Singleton Mark Leonardofficer: SVP & CFO
SellTue Mar 24
Singleton Mark Leonardofficer: SVP & CFO
SellTue Mar 17
Singleton Mark Leonardofficer: SVP & CFO
SellTue Mar 17
Singleton Mark Leonardofficer: SVP & CFO
SellTue Mar 17

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NASDAQ

Beta

0.69

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Peers